Evaluation of the modified immune prognostic index to prognosticate outcomes in metastatic uveal melanoma patients treated with immune checkpoint inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of the modified immune prognostic index to prognosticate outcomes in metastatic uveal melanoma patients treated with immune checkpoint inhibitors

Published:2021-03-16 Issue:8 Volume:10 Page:2618-2626
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Sander Michael S.¹^ORCID,Stukalin Igor²,Vallerand Isabelle A.¹³,Goutam Siddhartha⁴,Ewanchuk Benjamin W.¹,Meyers Daniel E.²^ORCID,Pabani Aliyah²,Morris Don G.²,Heng Daniel Y. C.²,Cheng Tina²

Affiliation:

1. Cumming School of Medicine University of Calgary Calgary AB Canada

2. Tom Baker Cancer Centre University of Calgary Calgary AB Canada

3. Section of Dermatology University of Calgary Calgary AB Canada

4. Faculty of Medicine and Dentistry University of Alberta Calgary AB Canada

Funder

Alberta Cancer Foundation

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3784

Reference41 articles.

1. Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours

2. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma

3. Uveal melanoma: From diagnosis to treatment and the science in between

4. Very Long-Term Prognosis of Patients with Malignant Uveal Melanoma

5. MALIGNANT MELANOMAS OF THE HUMAN UVEA

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis;Scientific Reports;2024-04-03

2. Case Report: Long-term metabolic response of metastatic uveal melanoma to pembrolizumab on FDG-PET/CT despite a serial pseudoprogressions phenomenon;Frontiers in Immunology;2023-12-04

3. Efficacy and Safety of Immune Checkpoint Blockades in the Treatment of Ocular Melanoma: A Systematic Review and Meta-Analysis;Frontiers in Oncology;2021-12-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3